Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick M Bossuyt

Showing results (11-20 of 272) with videos related to

Pageof 28
Sort By:
Human Genetics|April 14, 2011
Genomic markers to tailor treatments: waiting or initiating?Parvin Tajik, Patrick M Bossuyt
EJIFCC|September 30, 2016
Evaluating Biomarkers for Guiding Treatment DecisionsPatrick M Bossuyt, Tajik Parvin
Cancer Epidemiology|July 31, 2012
Cancer risk models and preselection for screeningInge Stegeman, Patrick M Bossuyt
Lancet (London, England)|January 9, 2003
The STARD initiativePatrick M Bossuyt, Johannes B Reitsma,
Clinical Chemistry|April 18, 2013
Reporting the accuracy of diagnostic tests: the STARD initiative 10 years onEleanor A Ochodo, Patrick M Bossuyt
Statistics in Medicine|July 6, 2007
We should not pool diagnostic likelihood ratios in systematic reviewsAeilko H Zwinderman, Patrick M Bossuyt
Radiology|June 29, 2004
Needle size in CT-guided transthoracic needle aspiration biopsy: complications and accuracyJeroen C van Rijn, Patrick M Bossuyt
Annals of Internal Medicine|March 15, 2021
On the Origin of Sensitivity and SpecificityNicholas Binney, Christopher Hyde, Patrick M Bossuyt
Journal of Clinical Epidemiology|March 30, 2018
From the theoretical to the practical: how to evaluate the ethical and scientific justifications of randomized clinical trialsMaria Olsen, Melissa K Sharp, Patrick M Bossuyt
Liver International : Official Journal of the International Association for the Study of the Liver|March 29, 2025
Response to: Precision in Diagnosis of Liver Fibrosis in MASLD: Machine Learning Based Scores May Be More Accurate Than Conventional NITsYasaman Vali, Quentin M Anstee, Patrick M Bossuyt
Pageof 28

Showing results (11-20 of 272) with videos related to

Sort By:
Pageof 28
Human Genetics|April 14, 2011
Genomic markers to tailor treatments: waiting or initiating?Parvin Tajik, Patrick M Bossuyt
EJIFCC|September 30, 2016
Evaluating Biomarkers for Guiding Treatment DecisionsPatrick M Bossuyt, Tajik Parvin
Cancer Epidemiology|July 31, 2012
Cancer risk models and preselection for screeningInge Stegeman, Patrick M Bossuyt
Lancet (London, England)|January 9, 2003
The STARD initiativePatrick M Bossuyt, Johannes B Reitsma,
Clinical Chemistry|April 18, 2013
Reporting the accuracy of diagnostic tests: the STARD initiative 10 years onEleanor A Ochodo, Patrick M Bossuyt
Statistics in Medicine|July 6, 2007
We should not pool diagnostic likelihood ratios in systematic reviewsAeilko H Zwinderman, Patrick M Bossuyt
Radiology|June 29, 2004
Needle size in CT-guided transthoracic needle aspiration biopsy: complications and accuracyJeroen C van Rijn, Patrick M Bossuyt
Annals of Internal Medicine|March 15, 2021
On the Origin of Sensitivity and SpecificityNicholas Binney, Christopher Hyde, Patrick M Bossuyt
Journal of Clinical Epidemiology|March 30, 2018
From the theoretical to the practical: how to evaluate the ethical and scientific justifications of randomized clinical trialsMaria Olsen, Melissa K Sharp, Patrick M Bossuyt
Liver International : Official Journal of the International Association for the Study of the Liver|March 29, 2025
Response to: Precision in Diagnosis of Liver Fibrosis in MASLD: Machine Learning Based Scores May Be More Accurate Than Conventional NITsYasaman Vali, Quentin M Anstee, Patrick M Bossuyt
Pageof 28